| |
 |
|
Class Information
Number: 424/259.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Klebsiella (e.g., klebsiella pneumoniae, etc.)
Description: Subject matter wherein the bacterium is of the genus Klebsiella.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7608247 |
Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation |
Oct. 27, 2009 |
| 7408044 |
Carrier protein having an adjuvant effect |
Aug. 5, 2008 |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7125696 |
Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
Oct. 24, 2006 |
| 7090853 |
Noscapine derivatives as adjuvant compositions and methods of use thereof |
Aug. 15, 2006 |
| 7033591 |
Immunostimulant bacterial membrane fractions in cancer treatment |
Apr. 25, 2006 |
| 7018636 |
Vaccine against Gram-negative bacterial infections |
Mar. 28, 2006 |
| 6913753 |
Incapacitated whole-cell immunogenic bacterial compositions |
Jul. 5, 2005 |
| 6905691 |
Vaccines containing attenuated bacteria |
Jun. 14, 2005 |
| 6780420 |
Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine |
Aug. 24, 2004 |
| 6632431 |
Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same |
Oct. 14, 2003 |
| 6423320 |
Inhibitor of immunoglobulin E antibody production |
Jul. 23, 2002 |
| 6197929 |
Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine |
Mar. 6, 2001 |
| 6083928 |
Skin healing method |
Jul. 4, 2000 |
| 6045805 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Apr. 4, 2000 |
| 6027736 |
Active immunization using a siderophore receptor protein |
Feb. 22, 2000 |
| 6007818 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Dec. 28, 1999 |
| 5997881 |
Method of making non-pyrogenic lipopolysaccharide or A |
Dec. 7, 1999 |
| 5906826 |
Method of inducing an immune response in a young animal |
May. 25, 1999 |
| 5538733 |
Method of priming an immune response in a one-day old animal |
Jul. 23, 1996 |
| 5538733 |
Method of priming an immune response in a one-day old animal |
Jul. 23, 1996 |
| 5538727 |
Anti-cholesterolemic vaccine |
Jul. 23, 1996 |
| 5538727 |
Anti-cholesterolemic vaccine |
Jul. 23, 1996 |
| 4764370 |
Vaccine utilizing an avirulent strain of Salmonella typhimurium |
Aug. 16, 1988 |
| 4755381 |
Klebsiella capsular polysaccharide vaccine |
Jul. 5, 1988 |
| 4663160 |
Vaccines for gram-negative bacteria |
May. 5, 1987 |
| 4606919 |
Vaccine for the treatment of urinary tract infections containing aluminum phosphate |
Aug. 19, 1986 |
| 4460575 |
Vaccinal complex containing a specific antigen and vaccine containing it |
Jul. 17, 1984 |
| 4402939 |
Vaccinating glycopeptidic antigenic fraction with a very high level of immunogenicity, isolated from cultures of pathogenic germs, processes for isolating said fraction and vaccines containing |
Sep. 6, 1983 |
| 4396607 |
Muramyl peptide derivatives and pharmaceutical compositions |
Aug. 2, 1983 |
| 4356171 |
Novel glycoproteins |
Oct. 26, 1982 |
| 4349540 |
Process for preparing vaccines based on antigenic ribosomal fractions |
Sep. 14, 1982 |
|
|
|
